Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial showsBy Press Room20 December 2024 Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in…
Biden devotes $150 million to moonshot goal of ending ‘cancer as we know it’By Press Room13 August 2024 The president and first lady Jill Biden will tour medical facilities, then, at Tulane University, will help announce $150 million…
Cancer patient who won $1.3 billion lottery said he would find a good doctor for himself—’I don’t want to die yet,’ he prayedBy Press Room30 April 2024 One of the winners of a $1.3 billion Powerball jackpot this month is an immigrant from Laos who has had cancer for…
Olivia Munn: Breast Cancer Risk Assessment Tool ‘saved my life’By Press Room14 March 2024 Olivia Munn had a double mastectomy last year after being diagnosed with an “aggressive, fast-moving” form of breast cancer, she…